E- and A-type cyclins as markers for cancer diagnosis and prognosis
- 1 September 2003
- journal article
- review article
- Published by Informa UK Limited in Expert Review of Molecular Diagnostics
- Vol. 3 (5), 617-633
- https://doi.org/10.1586/14737159.3.5.617
Abstract
Cyclin-dependent kinase (CDK)2 interacting cyclins perform essential functions for DNA replication and cellular proliferation. The human genome encodes two E-type cyclins (E and E2) and two A-type cyclins (A1 and A2). Dysregulation of the CDK2-bound cyclins plays an important role in the pathogenesis of cancer. Cyclin A2 is associated with cellular proliferation and can be used for molecular diagnostics as a proliferation marker. In addition, cyclin A2 expression is associated with a poor prognosis in several types of cancer. Cyclin A1 is a tissue-specific cyclin that is highly expressed in acute myeloid leukemia and in testicular cancer. High levels of cyclin E expression are found in many types of cancer. Overexpression of cyclin E at the mRNA level can be based on gene amplification and transcriptional mechanisms. In addition, proteolytically cleaved forms of cyclin E that show oncogenic functions have been described. Cyclin E plays a critical role for G1/S transition. Its overexpression is not only associated with proliferation but rather indicates a more malignant phenotype which is likely to be linked to the induction of chromosomal instability. These biological functions of cyclin E relate to a poor prognosis when high cyclin E levels are found. The link between cyclin E and poor prognosis is well established in breast and lung cancer but is likely to be observed in other cancers as well. The second E-type cyclin, cyclin E2, has been shown to be overexpressed in breast cancers although the potential role as a diagnostic or prognostic marker is unknown. This review provides an overview of the potential of cyclins E and A as markers for diagnosis and prognosis in human cancer.Keywords
This publication has 37 references indexed in Scilit:
- Cell Cycle and CancerBMB Reports, 2003
- Tumor-Specific Proteolytic Processing of Cyclin E Generates Hyperactive Lower-Molecular-Weight FormsMolecular and Cellular Biology, 2001
- Cyclin E induction by genotoxic stress leads to apoptosis of hematopoietic cellsOncogene, 2000
- Abnormalities in Cell Cycle Control in Cancer and Their Clinical ImplicationsTumori Journal, 1998
- Human Cytomegalovirus Inhibits Cellular DNA Synthesis and Arrests Productively Infected Cells in Late G1Virology, 1996
- Role of the cyclin-dependent kinase inhibitors in the development of cancerBlood, 1995
- Confirmational changeNature, 1995
- Human Cyclin E, a Nuclear Protein Essential for the G1-to-S Phase TransitionMolecular and Cellular Biology, 1995
- Principles of CDK regulationNature, 1995
- Association of human cyclin E with a periodic G1-S phase protein kinaseScience, 1992